RCGP eLearning Podcast

People living with severe mental illness face one of the greatest health equality gaps in England. Their life expectancy is 15–20 years shorter than that for the general population, and this disparity is largely due to preventable physical illnesses. In this podcast, Dr Thomas Round discusses physical health in people with severe mental illness with Professor Carolyn Chew-Graham, a Professor of General Practice Research at Keele University and a GP in Manchester and Dr David Shiers, Honorary Research Consultant at Psychosis Research Unit and a former GP in North Staffordshire, who became involved in the early intervention reform after his daughter’s experience of a severe psychotic illness. This podcast falls within the Mental Health curriculum field.RCGP Podcast FeedbackYour feedback plays a crucial role in helping us improve the CPD products and services we offer. We would be grateful if you could please complete our short RCGP Podcast Survey, which will take no more than 5 minutes to complete.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of drugs initially developed to treat type 2 diabetes and are now becoming more widely used for obesity. They work by mimicking the actions of the GLP-1 hormone, which is released by the gut after eating. GPs will be used to prescribing them for type 2 diabetes, but less so for obesity. In this podcast, Dr Thomas Round discusses the evolving role of GLP1-RA in obesity, the benefits and potential side effects, the role of the GP, and the latest NICE guidance in this area with Dr Stephanie DiGiorgio, an urgent care GP with a specialist interest in obesity. This podcast falls within the Metabolic Problems and Endocrinology curriculum field.RCGP Podcast FeedbackYour feedback plays a crucial role in helping us improve the CPD products and services we offer. We would be grateful if you could please complete our short RCGP Podcast Survey, which will take no more than 5 minutes to complete.

In this podcast, Dr Emma Nash speaks to Dr Jim Moore, a GP with a special interest in cardiovascular medicine and past president of the Primary Care Cardiovascular Society, about chronic kidney disease. The approach to diagnosis and categorisation is discussed, along with when further investigations or referral may need to be considered. Recognising that the majority of CKD is managed in primary care, Jim explains the key areas to target in terms of optimising outcome and reducing complications, along with how to talk about CKD with patients. He also gives an overview of the most important medications in CKD management, and the key things that GPs need to know about them.Production, editorial, and distribution owned by the Royal College of General Practitioners.

Testosterone deficiency in men can often cause erectile dysfunction or loss of libido, and should be considered whenever a man presents with these symptoms. However there are many other symptoms which can be missed. This podcast looks at potential presentations of testosterone deficiency, along with associated conditions, and explores how we might investigate and manage this important problem.An educational grant was received from Besins Healthcare for the production of this podcast. Editorial and content decisions were made solely by the RCGP.

In this 15 minute podcast, Dr Michael Mulholland, RCGP Honorary Secretary, talks to Dr Joy Shacklock, GP and RCGP Clinical Policy Representative for Safeguarding, about the new RCGP safeguarding standards. Joy explains the new document and the drivers behind the updates, as well as the supporting resources and how they can be used. In particular, she highlights the new all-age safeguarding toolkit and how to get the best out of it, along with pointers on safeguarding training and updated revalidation requirements. This podcast was produced by RCGP Learning. Editorial and content decisions were made solely by the RCGP.

Sponsored by Pfizer Limited. Pfizer has had no involvement in the editorial component of this educational material. Editorial and content decisions were made solely by the RCGP.Respiratory syncytial virus (RSV) is an RNA virus which causes respiratory infections; the most significant clinical effects are in infants and people who are elderly and have chronic medical conditions or immunosuppression. In this podcast, Professor Simon de Lusignan from the RCGP’s Research and Surveillance Centre discusses the new RSV vaccination programme, which offers a one-off vaccine to everyone at the age of 75, with an initial catch-up programme between the ages of 75 and 80. He also touches on monoclonal antibodies and antivirals, which are given in secondary care to children who are at high risk of serious complications if they contract RSV.Reviewed: March 2026

Both the combined and progestin-only pills are highly effective with perfect use, with a failure rate of less than 1%. However, the failure rate with “typical use” is 9%, which accounts for inconsistent or incorrect use.In this podcast Dr Thomas Round, a GP and EKU Clinical Lead, talks to Dr Toni Hazell, a GP with an interest in women's health and the RCGP Deputy Medical Director for eLearning about the types of combined oral contraception, risk assessment tools e.g. UKMEC, contraindications, individualising pill taking regimes, missed pill rules and common myths. This podcast falls within the Sexual health curriculum field.RCGP Podcast FeedbackYour feedback plays a crucial role in helping us improve the CPD products and services we offer. We would be grateful if you could please complete our short RCGP Podcast Survey, which will take no more than 5 minutes to complete.